MarginsXMarginsX
Home › Markets › Health Care › SNDL

SNDL Inc. Common Shares (SNDL)

SNDL trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.34
-2.19% on the day
Market cap
$326.0M
Small cap
Revenue · 2025
$663.8M
+2.8% on 2024
Net income · 2025
-$11.1M
-1.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 40-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1766600/000119312526102524/0001193125-26-102524-index.htm. Net income: SEC 40-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), fiscal year ended 2025-12-31. Converted from CAD at 1.4258 per USD (today's ECB or Federal Reserve reference rate).

Profile

FieldValue
TickerSNDL on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryCanada
IPO year2019
SEC CIK0001766600
SEC industry codeMedicinal Chemicals & Botanical Products
Incorporated inAB
Canadian listingCSE: SNDL

Financials · 2025

LineValue
Revenue$663.8M
Net income-$11.1M
Operating income-$4.5M
Net margin-1.7%
Operating margin-0.7%
Revenue growth+2.8%
Cash$176.9M
Total assets$937.0M
P/E (computed)Net income was not positive
P/S (computed)0.5×

Reported in CAD; shown in US dollars.

Warning signs

Cash runway
Cash-flow positive
252.2M CAD cash at December 31, 2025
Share count, 1 year
+0.1%
2024-12-31 to 2025-12-31 · +12.0% over 3 years
Going-concern doubt
No
40-F filed March 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.40-F 2026-03-12
Cash and burn252.2M CAD cash; operating cash flow 17.7M CAD a quarter.Report 2025-12-31
Shares outstanding263,359,123 (2025-12-31); 263,021,847 a year earlier; 235,194,236 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCBIZ CPAs P.C., New York, New York, United StatesPCAOB Form AP 2026-03-16
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
946.4M CAD-15.8M CAD70.9M CAD252.2M CADNo debt tags946.4M CAD40-F 2026-03-12
FY 2024
2024-12-31
920.4M CAD-94.8M CAD54.9M CAD218.4M CADNo debt tags920.4M CAD40-F 2026-03-12
FY 2023
2023-12-31
909.0M CAD-172.7M CAD-16.6M CAD195.0M CADNo debt tags909.0M CAD40-F 2025-03-18
FY 2022
2022-12-31
712.2M CAD-335.1M CAD-6.7M CAD279.6M CADNo debt tags712.2M CAD20-F/A 2024-03-21
FY 2021
2021-12-31
56.1M CAD-227.0M CAD-155.8M CAD558.3M CADNo debt tags56.1M CAD20-F/A 2024-03-21
FY 2020
2020-12-31
60.9M CAD-233.2M CAD-57.5M CAD60.4M CADNo debt tags60.9M CAD20-F/A 2024-03-21
FY 2019
2019-12-31
63.6M CAD-271.5M CAD-112.7M CAD45.3M CAD177.9M CAD63.6M CAD20-F 2022-04-28
FY 2018
2018-02-28
Not filed-13.0M CAD-5.2M CAD7.7M CAD7.0M CADNeeds four quarters20-F 2020-03-31

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in CAD.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52021-03-22
Latest annual report40-F2026-03-12
Latest quarterly / interim
FORM 6-K
6-K2026-10-27

Source: SEC EDGAR submissions feed, 406 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-3.2%
1 month+18.1%
3 months+9.6%
Year to date-17.5%
1 year-19.4%
From 52-week high-38.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
TLRYTilray Brands Inc. Common Stock$2.34-3.70%$345.8M
ACBAurora Cannabis Inc. Common Shares$4.61-6.68%$303.1M
USNAUSANA Health Sciences Inc.$13.54+2.27%$250.3M
CGCCanopy Growth Corporation Common Shares$0.5460-2.71%$231.2M
MDWDMediWound Ltd.$13.55+5.04%$195.0M
OBIOOrchestra BioMed Holdings Inc.$7.12-1.79%$560.4M
NAGENiagen Bioscience Inc.$2.01-2.66%$159.2M
GLASGlass House Brands Inc. Subordinate Voting Shares$1.29+1.57%$113.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier